Consumer Driven Health Care

Grail is focusing on early detection and cutting life insurance market sales teams.

After top drugmakers unsuccessfully tried to squash the program, HHS has finally reached agreements with Merck, Novartis and others to lower prices for the first 10 drugs included in the Medicare Drug Price Negotiation Program.

The purchase is subject to bankruptcy court approval, and the transaction will close pending completion of all closing conditions, including regulatory approval.

Three out of five Americans admitted to avoiding an important health screening over the last year – up 20% from 2023.

Federal transparency rules took effect in 2022 but have not worked well.

Nearly 1 in 5 patients were denied coverage by their insurer for a service that had been recommended by their doctor.